There are no drug label warnings or precautions for Ozempic users with hyperthyroidism, also known as overactive thyroid
(2004) 109(21 Suppl 1):II210
It was approved by the FDA in 2021 for chronic weight management in adults with obesity or overweight with at least one weight-related condition
For someone already taking a GLP-1 medication, this reinforces the idea that obesity treatment is not cosmetic its a chronic disease treatment and risk-reduction medication. GLP-1s Users Had Lower Rates of Blood Clots, ER Visits, and Death The study analyzed health records from more than 26,000 adults with obesity and at least one autoimmune disease, such as rheumatoid arthritis, psoriatic arthritis, type 1 diabetes, vitiligo, and celiac disease
San Ramons top-rated medical weight loss clinic in-person physician-guided GLP-1 programs with Semaglutide (Ozempic, Wegovy), Tirzepatide (Zepbound, Mounjaro), Retatrutide & oral GLP-1 options